Immune therapy scores big win against lung cancer in study
CHICAGO (AP) — New research suggests that many more lung cancer patients may benefit from treatments that boost the immune system, which have scored some of their biggest wins until now in less common forms of the disease.
One study found using one of these drugs — Merck's Keytruda (kee-TROO-dah) — with usual chemotherapy greatly improved survival for people newly diagnosed with the most common type of cancer that had spread beyond the lungs.
That's a first, and it's expected to quickly set a new standard of care for about 70,000 patients each year in the United States.
Trending Health News... read more
- 22:34 Woman's win of nursing home money a rarity in aging Japan
- 22:29 Game Day: Diamondbacks meet the Padres for first time in 2018
- 21:18 Patrick Corbin riding his slider to early-season dominance
- 20:49 Diamondbacks catcher Alex Avila is off to a rough start at the plate
- 20:24 Arizona Cardinals limiting Sam Bradford now in hopes of a healthier...
- 18:32 ASU football podcast: Reviewing the first spring under coach Herm...
- 18:28 No. 8 ASU softball hosts No. 13 Arizona looking to solidify NCAA...
- 18:20 2004 fraud case causes sparks in GOP party leader's race
- 17:50 Texasâ ârevenge pornâ law struck down by state appeals court
- 17:42 Rudy Giuliani to join Trump legal team in Russia probe